Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about major depressive disorder

Recent news which mentions major depressive disorder

Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
Tickers CYBN
Tags Psychedelic/Assisted Therapies Benzinga CYBN
From Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
Tickers MNMD
Tags Cannabis Market News major depressive disorder
From Benzinga
Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder
Tickers CMPS
Tags Markets cancer Psychedelics
From Benzinga
DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial
Tickers DMTTF
Tags News Psychedelic/Assisted Therapies Benzinga
From Benzinga
FSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder
Tickers HUGE
Tags News HUGE Benzinga
From Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
Tickers DMTTF
Tags Psychedelics Cannabis DMTTF
From Benzinga
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Tickers CMND
Tags Next/Generation Psychedelics Benzinga CMND
From Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
Tickers DMTTF
Tags Short/Acting Psychedelics News Earnings
From Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
Tickers DMTTF
Tags Cannabis DMTTF Psychedelics
From Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
Tickers DMTTF
Tags Benzinga DMT/Assisted Therapy News
From Benzinga
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder
Tickers EHVVF
Tags clinical trials Management Penny Stocks
From Benzinga
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
Tickers RLMD
Tags Biotech major depressive disorder Market News
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags Management Global MHRA
From Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
Tickers CYBN
Tags Markets Health Care Psychedelics
From Benzinga
New Zealand Government Grants $650K For LSD Microdosing Trials
Tickers BLRZF
Tags Market News major depressive disorder Cannabis
From Benzinga
How To Enroll In A Psychedelic Clinical Trial In 5 Easy Steps
Tags Benzinga Markets Psychedelics
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
Tags John Hopkins University Psilocybin Benzinga
From Benzinga
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
Tickers BIIB SAGE
Tags Health Care Benzinga Movers
From Benzinga
AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials
Tickers ABBV
Tags Health Care Briefs News
From Benzinga
B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock
Tickers SAGE SEEL
Tags Market News Price Target major depressive disorder
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.